PRO-DEX INC (PDEX) Stock Price, Quote, News and Overview
NASDAQ:PDEX - Nasdaq - US74265M2052 - Common Stock - Currency: USD
PDEX Quote, Performance and Key Statistics
PRO-DEX INC
NASDAQ:PDEX (1/27/2025, 11:18:26 AM)
41.5
+0.84 (+2.07%)
The current stock price of PDEX is 41.5 USD. In the past month the price decreased by -11.42%. In the past year, price increased by 88.94%.
PDEX Latest News, Press Releases and Analysis
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level.
PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results
Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results
PDEX Stock Earnings: Pro-Dex Misses EPS, Beats Revenue for Q3 2024
PDEX stock results show that Pro-Dex missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
PDEX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.63 | 223.78B | ||
| ISRG | INTUITIVE SURGICAL INC | 78.71 | 205.49B | ||
| SYK | STRYKER CORP | 34.08 | 151.24B | ||
| BSX | BOSTON SCIENTIFIC CORP | 42.95 | 149.40B | ||
| MDT | MEDTRONIC PLC | 17.44 | 117.39B | ||
| BDX | BECTON DICKINSON AND CO | 18.78 | 71.66B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 21.12 | 40.72B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.75 | 40.55B | ||
| RMD | RESMED INC | 30.9 | 37.60B | ||
| IDXX | IDEXX LABORATORIES INC | 39 | 34.97B | ||
| DXCM | DEXCOM INC | 51.82 | 34.41B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.18 | 25.60B |
Related stock screener links
About PDEX
Company Profile
Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 148 full-time employees. The firm has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. The company also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. The company has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).
Company Info
PRO-DEX INC
2361 McGaw Ave
Irvine CALIFORNIA 92614 US
CEO: Richard L. Van Kirk
Employees: 148
Company Website: https://www.pro-dex.com/
Investor Relations: http://www.pro-dex.com/investor-relations/
Phone: 19497693200
PDEX FAQ
What is the stock price of PDEX?
The current stock price of PDEX is 41.5 USD.
What is the symbol for PRO-DEX INC stock?
The exchange symbol of PRO-DEX INC is PDEX and it is listed on the Nasdaq exchange.
On which exchange is PDEX stock listed?
PDEX stock is listed on the Nasdaq exchange.
Is PDEX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PDEX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PDEX.
Does PDEX stock pay dividends?
PDEX does not pay a dividend.
When does PDEX stock report earnings?
PDEX will report earnings on 2025-02-06, after the market close.
What is the Price/Earnings (PE) ratio of PDEX?
The PE ratio for PDEX is 26.95. This is based on the reported non-GAAP earnings per share of 1.54 and the current share price of 41.5 USD.
What is the Short Interest ratio of PDEX stock?
The outstanding short interest for PDEX is 0.96% of its float.
PDEX Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to PDEX. When comparing the yearly performance of all stocks, PDEX is one of the better performing stocks in the market, outperforming 94.02% of all stocks.
PDEX Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to PDEX. PDEX scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
PDEX Financial Highlights
Over the last trailing twelve months PDEX reported a non-GAAP Earnings per Share(EPS) of 1.54. The EPS decreased by 81.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.17% | ||
| ROA | 9.59% | ||
| ROE | 16.87% | ||
| Debt/Equity | 0.36 |
PDEX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to PDEX. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 229.03% and a revenue growth 23.48% for PDEX